help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 12, 2005
Endocrinology, doi:10.1210/en.2005-0272
A more recent version of this article appeared on August 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
146/8/3409    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alimov, A. P.
Right arrow Articles by Koszewski, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alimov, A. P.
Right arrow Articles by Koszewski, N. J.

Submitted on March 8, 2005
Accepted on May 3, 2005

Transactivation of the parathyroid hormone promoter by Sp proteins and the nuclear factor Y complex

Alexander P. Alimov, Ok-Kyong Park-Sarge, Kevin D. Sarge, Hartmut H. Malluche, and Nicholas J. Koszewski*

University of Kentucky Medical Center, Division of Nephrology, Bone and Mineral Metabolism, 800 Rose Street, Lexington, KY 40536-0298; University of Kentucky Medical Center, Department of Physiology, 800 Rose Street, Lexington, KY 40536-0298, University of Kentucky Medical Center, Department of Molecular and Cellular Biochemistry, 800 Rose Street, Lexington, KY 40536-0298

* To whom correspondence should be addressed. E-mail: njhosz0{at}uky.edu.

We previously identified a highly conserved Sp1 DNA element in mammalian parathyroid hormone (PTH) promoters that acted as an enhancer of gene transcription and bound Sp1 and Sp3 proteins present in parathyroid gland nuclear extracts. More recently, an NF-Y element (NF-Yprox) was also described by our group, which was located approximately 30 bp downstream from the Sp1 site in the human PTH (hPTH) promoter and by itself acted as a weak enhancer of gene transcription. We now report that Sp-proteins and NF-Y can synergistically enhance transcription of a minimal hPTH promoter construct. Positioning of the Sp1 DNA element appears to be critical for this synergism as deviations of one-half of a helical turn caused an approximate 60% decrease in transactivation. Finally, examination of the bovine PTH (bPTH) promoter also revealed Sp1/NF-Y synergism, in conjunction with the identification of an analogous NF-Y binding site similarly positioned downstream from the bPTH Sp1 element. In summary, synergistic transactivation of the hPTH and bPTH promoters is observed by Sp-proteins and the NF-Y complex. The conservation of this transactivation in the human and bovine promoters suggests that this may be a principle means of enhancing PTH gene transcription.


Key words: gene transcription • synergism • vitamin D




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
M. C. Chia, A. Leung, T. Krushel, N. M. Alajez, K. W. Lo, P. Busson, H. J. Klamut, C. Bastianutto, and F.-F. Liu
Nuclear Factor-Y and Epstein Barr Virus in Nasopharyngeal Cancer
Clin. Cancer Res., February 15, 2008; 14(4): 984 - 994.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
Y. Jiang and S. S Stojilkovic
Molecular cloning and characterization of {alpha}1-soluble guanylyl cyclase gene promoter in rat pituitary cells
J. Mol. Endocrinol., December 1, 2006; 37(3): 503 - 515.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. J. Suva
PTH Expression, Not Always where You Think ...
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 396 - 397.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. N. VanHouten, N. Yu, D. Rimm, J. Dotto, A. Arnold, J. J. Wysolmerski, and R. Udelsman
Hypercalcemia of Malignancy due to Ectopic Transactivation of the Parathyroid Hormone Gene
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 580 - 583.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society